data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
ADMA Biologics
(NASDAQ:ADMA)
2.04
0.10[5.15%]
At close: May 27
1.98
-0.0600[-2.94%]
After Hours: 4:36PM EDT
Day High/Low1.91 - 2.09
52 Week High/Low1.01 - 2.15
Open / Close1.96 / 2.04
Float / Outstanding188.4M / 196.4M
Vol / Avg.2M / 2.6M
Mkt Cap400.6M
P/E-
50d Avg. Price1.88
Div / Yield-
Payout Ratio-
EPS-0.13
Total Float188.4M

ADMA Biologics (NASDAQ:ADMA), Quotes and News Summary

ADMA Biologics (NASDAQ: ADMA)

Day High/Low1.91 - 2.09
52 Week High/Low1.01 - 2.15
Open / Close1.96 / 2.04
Float / Outstanding188.4M / 196.4M
Vol / Avg.2M / 2.6M
Mkt Cap400.6M
P/E-
50d Avg. Price1.88
Div / Yield-
Payout Ratio-
EPS-0.13
Total Float188.4M
Benzinga - 4 days ago
Benzinga - May 12, 2022, 11:10AM
Benzinga - May 11, 2022, 5:16PM
Benzinga - May 11, 2022, 4:50PM
Benzinga - May 11, 2022, 4:49PM
Benzinga - Mar 25, 2022, 8:34AM
Benzinga - Mar 25, 2022, 7:00AM
Benzinga - Mar 24, 2022, 4:10PM
Benzinga - Mar 7, 2022, 4:06PM
Benzinga - Jan 19, 2022, 10:55AM
Benzinga - Jan 19, 2022, 7:23AM
Benzinga - Jan 18, 2022, 7:29AM
Benzinga - Dec 9, 2021, 7:06AM
Benzinga - Nov 16, 2021, 7:11AM
Benzinga - Nov 11, 2021, 7:49AM
Benzinga - Nov 11, 2021, 7:26AM
Benzinga - Nov 10, 2021, 4:03PM
load more
Sector: Health Care.Industry: Biotechnology
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-10
REV
Q1 2022Est.ActualSurprise
EPS-0.080-0.100 -0.0200
REV27.690M29.103M1.413M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

ADMA Biologics Questions & Answers

Q
How do I buy ADMA Biologics (ADMA) stock?
A

You can purchase shares of ADMA Biologics (NASDAQ: ADMA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are ADMA Biologics's (ADMA) competitors?
Q
What is the target price for ADMA Biologics (ADMA) stock?
A

The latest price target for ADMA Biologics (NASDAQ: ADMA) was reported by Raymond James on Thursday, November 11, 2021. The analyst firm set a price target for 5.00 expecting ADMA to rise to within 12 months (a possible 145.10% upside). 5 analyst firms have reported ratings in the last year.

Q
Current Stock Price for ADMA Biologics (ADMA)?
A

The stock price for ADMA Biologics (NASDAQ: ADMA) is $2.04 last updated May 27, 2022, 8:00 PM UTC.

Q
Does ADMA Biologics (ADMA) pay a dividend?
A

There are no upcoming dividends for ADMA Biologics.

Q
When is ADMA Biologics (NASDAQ:ADMA) reporting earnings?
A

ADMA Biologics’s Q2 earnings are confirmed for Wednesday, August 10, 2022.

Q
Is ADMA Biologics (ADMA) going to split?
A

There is no upcoming split for ADMA Biologics.

Q
What sector and industry does ADMA Biologics (ADMA) operate in?
A

ADMA Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.